Wilbert Bannenberg Technical Director International MeTA Secretariat 30 May 2009, Amman, Jordan Medicines Transparency Alliance (MeTA): Country progress and key lessons MeTA 16/09/2008

What is MeTA? An innovative and comprehensive approach An international & national multi-stakeholder alliance designed to: support country efforts to increase access to medicines across the whole supply chain improve the flow of information and increase transparency on price, quality, availability and promotion support stronger governance and accountability and share learning 16/09/2008 MeTA

An innovative and comprehensive approach

An international & national multi-stakeholder alliance designed to:

support country efforts to increase access to medicines across the whole supply chain

improve the flow of information and increase transparency on price, quality, availability and promotion

support stronger governance and accountability and share learning

MeTA Principles Commitment to improving health Comprehensive approach to health systems, including pharmaceuticals Transparency and accountability can: Improve system performance Build confidence Support equity and social justice It takes us all working together to bring about the change we need 16/09/2008 MeTA

Commitment to improving health

Comprehensive approach to health systems, including pharmaceuticals

Transparency and accountability can:

Improve system performance

Build confidence

Support equity and social justice

It takes us all working together to bring about the change we need

MeTa Country commitments Establish an effective multi-stakeholder forum with public, private and civil society engagement Progressive disclosure of data in four areas Quality Regulatory, sourcing, quality assurance, vigilance Availability Supply chain operations, equitable access Price Supplier, wholesaler, retailer, import taxes, duties, affordability Promotion Objective information, rational use, ethical advertising 16/09/2008 MeTA

Establish an effective multi-stakeholder forum with public, private and civil society engagement

Progressive disclosure of data in four areas

Quality Regulatory, sourcing, quality assurance, vigilance

Availability Supply chain operations, equitable access

Price Supplier, wholesaler, retailer, import taxes, duties, affordability

Promotion Objective information, rational use, ethical advertising

MeTA Pilot Countries 16/09/2008 MeTA

MeTA Pilot objectives Add value to country ATM efforts through transparency and multi-stakeholder working Road test the MeTA approach in different country settings Engage stakeholders at country and int’l levels Provide a model for eventual roll out in further countries 16/09/2008 MeTA

Add value to country ATM efforts through transparency and multi-stakeholder working

Road test the MeTA approach in different country settings

Engage stakeholders at country and int’l levels

Provide a model for eventual roll out in further countries

MeTA implementation process Stakeholders engaged MeTA Council formed MeTA Secretariat formed Pre-MoU work done MoU signed Work started GHANA JORDAN KYRGYZSTAN PERU PHILIPPINES UGANDA ZAMBIA 16/09/2008 MeTA

Specific Success or Milestone 16/09/2008 GHANA JORDAN KYRGYZSTAN PERU PHILIPPINES UGANDA ZAMBIA Establishment of the physical secretariat Full support of government and private sector Identifying the stakeholders and approval of the work plan Sign MoU because it is final point Successful forums and especially the CSO Forum in Jan 2009 Successful launch and the receiving of funds Successful launch and media interest

Key Challenges to MeTA implementation Stakeholder engagement and maintaining interest Insufficient legislation/regulation and excessive bureaucracy Difficulties in extracting information Lack of tools for accessing information 16/09/2008 MeTA

Stakeholder engagement and maintaining interest

Insufficient legislation/regulation and excessive bureaucracy

Difficulties in extracting information

Lack of tools for accessing information

Lessons learned in countries Contexts are different in every country, so local conditions determine the pace and content of the work. It takes time to get the right people at the table, build trust and develop a working relationship among stakeholders. Consensus builds with a constant exchange of views. Stakeholder commitment is key to a successful process. Some problems in the medicines supply chain require tough political action to solve. Starting work on less controversial issues is key. Systems and structures for disclosing data often do not exist in countries and may have to be created. 16/09/2008 MeTA

Contexts are different in every country, so local conditions determine the pace and content of the work.

It takes time to get the right people at the table, build trust and develop a working relationship among stakeholders.

Consensus builds with a constant exchange of views.

Stakeholder commitment is key to a successful process.

Some problems in the medicines supply chain require tough political action to solve. Starting work on less controversial issues is key.

Systems and structures for disclosing data often do not exist in countries and may have to be created.

Key priorities for MeTA Progressive disclosure of data about medicines Developing and testing a new multi-stakeholder approach and preparing stakeholders for meaningful engagement Ensuring the strong engagement of the private sector at country and international level Increasing the voice of patients and consumers and strengthening capacity and opportunity for their engagement Documenting innovation, change and good practice across the programme. 16/09/2008 MeTA

Progressive disclosure of data about medicines

Developing and testing a new multi-stakeholder approach and preparing stakeholders for meaningful engagement

Ensuring the strong engagement of the private sector at country and international level

Increasing the voice of patients and consumers and strengthening capacity and opportunity for their engagement

Documenting innovation, change and good practice across the programme.

Congratulations to Jordan on the successful establishment and launch of MeTA and every good wish for the success of the programme here. International Secretariat, [email_address] www.MedicinesTransparency.org 16/09/2008 MeTA

Congratulations to Jordan on the successful establishment and launch of MeTA and every good wish for the success of the programme here.

International Secretariat, [email_address]

www.MedicinesTransparency.org